Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126690981 | 12669098 | 1 | I | 20160812 | 20160820 | 20160820 | EXP | US-ASTRAZENECA-2016SE87826 | ASTRAZENECA | 0.00 | M | Y | 0.00000 | 20160820 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126690981 | 12669098 | 1 | PS | ATENOLOL. | ATENOLOL | 1 | Oral | 0 | 25 | MG | TABLET | QD | |||||||
| 126690981 | 12669098 | 2 | SS | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | Y | 0 | TABLET | |||||||||
| 126690981 | 12669098 | 3 | SS | SIMVASTATIN. | SIMVASTATIN | 1 | Unknown | Y | 0 | ||||||||||
| 126690981 | 12669098 | 4 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Oral | 0 | 50 | MG | TABLET | BID | |||||||
| 126690981 | 12669098 | 5 | C | RAMIPRIL. | RAMIPRIL | 1 | Oral | 0 | 2.5 | MG | CAPSULE | QD | |||||||
| 126690981 | 12669098 | 6 | C | CLOPIDOGREL | CLOPIDOGREL BISULFATE | 1 | Oral | 0 | 75 | MG | QD | ||||||||
| 126690981 | 12669098 | 7 | C | ASPIRIN. | ASPIRIN | 1 | Oral | 0 | 81 | MG | TABLET | QD | |||||||
| 126690981 | 12669098 | 8 | C | VITAMIN D3 | CHOLECALCIFEROL | 1 | 1000 UNITS A DAY | 0 | |||||||||||
| 126690981 | 12669098 | 9 | C | FISH OIL | FISH OIL | 1 | 1200 MG | 0 | |||||||||||
| 126690981 | 12669098 | 10 | C | MULTIVITAMIN | VITAMINS | 1 | DAILY | 0 | |||||||||||
| 126690981 | 12669098 | 11 | C | ZETIA | EZETIMIBE | 1 | Oral | 0 | 100 | MG | TABLET | QD | |||||||
| 126690981 | 12669098 | 12 | C | LANTUS | INSULIN GLARGINE | 1 | 14-16 UNITS A DAY | 0 | |||||||||||
| 126690981 | 12669098 | 13 | C | LIPITOR | ATORVASTATIN CALCIUM | 1 | Oral | 0 | |||||||||||
| 126690981 | 12669098 | 14 | C | LIPITOR | ATORVASTATIN CALCIUM | 1 | OTHER BRANDS OF LIPITOR | 0 | |||||||||||
| 126690981 | 12669098 | 15 | C | LIPITOR | ATORVASTATIN CALCIUM | 1 | Oral | 0 | 80 | MG | TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126690981 | 12669098 | 1 | Cardiac disorder |
| 126690981 | 12669098 | 4 | Diabetes mellitus |
| 126690981 | 12669098 | 5 | Cardiac disorder |
| 126690981 | 12669098 | 9 | Cardiac disorder |
| 126690981 | 12669098 | 11 | Cardiac disorder |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126690981 | 12669098 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126690981 | 12669098 | Cardiac discomfort | |
| 126690981 | 12669098 | Drug hypersensitivity | |
| 126690981 | 12669098 | Myalgia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |